The group of about 20 diseases, which show overlapping symptoms that typically include nerve cell death, share a similar genetic mutation mechanism - but how this form of mutation causes these diseases has remained a mystery.
"Despite the genes for some of these diseases having been identified 20 years ago, we still haven't understood the underlying mechanisms that lead to people developing clinical symptoms," said Professor Robert Richards, Head of Genetics in the University of Adelaide's School of Molecular and Biomedical Sciences.
Researchers have found new evidence for the key role of RNA in the development of the diseases.
RNA is a large molecule in the cell that copies genetic code from the cell's DNA and translates it into the proteins that drive biological functions.
People with these diseases have expanded numbers of copies of particular sequences of the 'nucleotide bases' which make up DNA.
"The disease develops when people have too many copies of the repeat sequence. Above a certain threshold, the more copies they have, the earlier the disease develops and the more severe the symptoms.
"The current gap in knowledge is why having these expanded repeat sequences of genes in the RNA translates into actual symptoms," he said.
Richards said evidence points towards a dysfunctional RNA and a pivotal role of the body's immune system in the development of the disease.
"Rather than recognising the 'expanded repeat RNA' as its own RNA, we believe the 'expanded repeat RNA' is being seen as foreign, like the RNA in a virus, and this activates the innate immune system, resulting in loss of function and ultimately the death of the cell," he said.
"This new understanding, once proven in each of the relevant human diseases, opens the way for potential treatments, and should give cause for hope to those with these devastating diseases," Richards said.
The study was published in journal Frontiers in Molecular Neuroscience.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
